Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S7 pseudogene 7 (RPS7P7) is a processed pseudogene in the human genome related to the coding gene ribosomal protein S7 (RPS7), which encodes a structural component of the small (40S) ribosomal subunit[1][3][4]. Unlike its protein-coding counterpart, RPS7P7 has lost the ability to code for a functional protein and is not known to have a biological or therapeutic function. Pseudogenes like RPS7P7 arise from duplication or retrotransposition events of functional genes but accumulate mutations that prevent them from producing proteins. There is no evidence that RPS7P7 is involved in disease, drug targeting, signaling, or cell biology, and it does not serve as a biomarker or therapeutic target[3][4].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S7 pseudogene 7 (RPS7P7).